Last updated: November 21, 2023
Sponsor: Centre Jean Perrin
Overall Status: Terminated
Phase
N/A
Condition
N/ATreatment
Home-based Adapted Physical Activity
Clinical Study ID
NCT02963363
2016-A01344-47
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Women > 18 years old
- Patient with HER2 (Human Epidermal growth factor Receptor 2) positive breast cancerhistologically proven, eligible for neoadjuvant chemotherapy and targeted therapyagainst HER-2
- Affiliation to the French social security scheme
- Patient who signed the participation consent before entering the trial
- Medical fitness certificate for sport
Exclusion
Exclusion Criteria:
- Diagnosis of a second malignancy in the past 5 years, with the exception of a basalcell skin cancer
- Metastatic cancer
- Karnofsky index ≤ 90%
- Men
- Pregnant women
- Significant psychiatric or neurological abnormality
- Patient deprived of liberty by a court or administrative
- Contraindication for physical activity
- Patient unable to complete questionnaires (language barrier)
- Participation in a clinical trial with the same objective
Study Design
Total Participants: 36
Treatment Group(s): 1
Primary Treatment: Home-based Adapted Physical Activity
Phase:
Study Start date:
April 27, 2018
Estimated Completion Date:
August 11, 2023
Study Description
Connect with a study center
Centre Jean Perrin
Clermont-Ferrand, 63011
FranceSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.